Royal Doctors
ActiveSummary
The annual accounts of Royal Doctors for fiscal year 2025 show a net loss of 65% of total assets. The 2025 annual accounts show equity of €205,342 and a net result of -€191,112. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 57% of 16810 sector peers (fiscal year 2025). The company has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
59
/ 100
Fair
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency95▲+6
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 3.09 against 2.94 in 2024; short-term debt: 25% and cash: 52.3% of total assets), and 29.8% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
70.2%
Return on assets
-65.4%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€191,112
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
14 d early
2024
27 d late
2023
31 d late
2022
on the day
2021
37 d early
2020
33 d early
2019
2 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 4 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (4 of the last 5 filed years within 32 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€205,342▼ 48.2%
2024 · €396,454
Total assets
€292,437▼ 52.7%
2024 · €618,760
Net result
-€191,112▲ 53.4%
2024 · -€409,708
Working capital
€152,808▼ 59.3%
2024 · €375,877
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€207,695▼ 533%-€308,608▼ 48.6%-€380,149▼ 23.2%-€395,018▼ 3.9%-€185,670▲ 53.0%
Net result-€215,147below the sector's middle half▼ 458%-€316,075below the sector's middle half▼ 46.9%-€397,358below the sector's middle half▼ 25.7%-€409,708below the sector's middle half▼ 3.1%-€191,112below the sector's middle half▲ 53.4%
Equity-€230,424below the sector's middle half▼ 1,408%-€296,499below the sector's middle half▼ 28.7%-€193,857below the sector's middle half▲ 34.6%€396,454above the sector's middle half€205,342within the sector's middle half▼ 48.2%
Total assets€189,455within the sector's middle half▼ 22.7%€142,457within the sector's middle half▼ 24.8%€344,323within the sector's middle half▲ 142%€618,760above the sector's middle half▲ 79.7%€292,437within the sector's middle half▼ 52.7%
Debt€419,879▲ 61.3%€438,956▲ 4.5%€538,180▲ 22.6%€222,305▼ 58.7%€87,094▼ 60.8%
Working capital-€171,980below the sector's middle half▼ 473%-€196,921below the sector's middle half▼ 14.5%€45,674within the sector's middle half€375,877above the sector's middle half▲ 723%€152,808within the sector's middle half▼ 59.3%
Solvency-121.6%below the sector's middle half▼ 115.4pp-208.1%below the sector's middle half▼ 86.5pp-56.3%below the sector's middle half▲ 151.8pp64.1%within the sector's middle half▲ 120.4pp70.2%within the sector's middle half▲ 6.1pp
Current ratio0.43below the sector's middle half▼ 0.420.33below the sector's middle half▼ 0.111.19below the sector's middle half▲ 0.862.94within the sector's middle half▲ 1.753.09within the sector's middle half▲ 0.15
Return on assets (ROA)-113.6%below the sector's middle half▼ 97.8pp-221.9%below the sector's middle half▼ 108.3pp-115.4%below the sector's middle half▲ 106.5pp-66.2%below the sector's middle half▲ 49.2pp-65.4%below the sector's middle half▲ 0.9pp
Staff (FTE)2.3▲ 53.3%3.7▲ 60.9%4.6▲ 24.3%4.9▲ 6.5%6▲ 22.4%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €185,670 in 2025 against €395,018 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €292,437
Fixed assets
€66,423 ▲ 35.3%
Current assets
€226,013 ▼ 60.3%
Equity and liabilities €292,437
Equity
€205,342 ▼ 48.2%
Debt
€87,094 ▼ 60.8%
Debt's share of the balance-sheet total falls from 35.9% to 29.8%. Equity and debt are lower.
Key figures and ratios
EBITDA
-€166,566▲
2024 · -€382,210
Cash flow
-€172,008▲
2024 · -€396,900
Debt to equity
0.42▼
2024 · 0.56
ROE
-93.1%▲
2024 · -103.3%
Interest coverage
-26.44▼
2024 · -21.64
Debt ≤ 1 year
€73,205▼
2024 · €193,793
Debt > 1 year
€13,889▼
2024 · €28,512
Income taxes
€176
Staff costs
€311,003▲
2024 · €240,406
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 4,805 companies that looked in July 2024 the way this one looks now, 2.0% went bankrupt within 24 months and 88% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a loss of 10% of the balance sheet or more
2.0%
went bankrupt
9.8%
stopped otherwise
88%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 4,805 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €537 | - | - | - | - | - |
| Remuneration, social security and pensions62 | €68,313 | €147,137 | €211,875 | €240,406 | €311,003 | ▲ 29.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €15,013 | €13,969 | €13,714 | €12,808 | €19,104 | ▲ 49.2% |
| Other operating charges640/8 | €3,380 | €2,060 | €2,139 | €1,775 | €823 | ▼ 53.6% |
| Non-recurring operating charges66A | €2,765 | - | - | €30,779 | - | - |
| Gross operating margin9900 | -€118,224 | -€145,443 | -€152,420 | -€109,250 | €145,260 | ▲ 233% |
| Operating profit (loss)9901 | -€207,695 | -€308,608 | -€380,149 | -€395,018 | -€185,670 | ▲ 53.0% |
| Financial income75/76B | €447 | €3 | €0 | €2,969 | €1,034 | ▼ 65.2% |
| Recurring financial income75 | €447 | €3 | €0 | €2,969 | €1,034 | ▼ 65.2% |
| Financial charges65/66B | €7,732 | €7,470 | €17,209 | €17,659 | €6,300 | ▼ 64.3% |
| Recurring financial charges65 | €7,732 | €7,470 | €17,209 | €17,659 | €6,300 | ▼ 64.3% |
| Profit (loss) for the period before taxes9903 | -€214,980 | -€316,075 | -€397,358 | -€409,708 | -€190,936 | ▲ 53.4% |
| Income taxes67/77 | €167 | - | - | - | €176 | - |
| Profit (loss) for the period9904 | -€215,147 | -€316,075 | -€397,358 | -€409,708 | -€191,112 | ▲ 53.4% |
| Profit (loss) for the period to be appropriated9905 | -€215,147 | -€316,075 | -€397,358 | -€409,708 | -€191,112 | ▲ 53.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €189,455 | €142,457 | €344,323 | €618,760 | €292,437 | ▼ 52.7% |
| Fixed assets21/28 | €58,333 | €46,677 | €57,533 | €49,090 | €66,423 | ▲ 35.3% |
| Intangible fixed assets21 | €23,984 | €17,984 | €11,984 | €5,984 | - | - |
| Tangible fixed assets22/27 | €28,350 | €22,694 | €19,549 | €17,106 | €33,738 | ▲ 97.2% |
| Plant, machinery and equipment23 | - | €716 | €2,586 | €2,228 | - | - |
| Furniture and vehicles24 | €21,541 | €15,607 | €11,031 | €9,384 | €28,681 | ▲ 206% |
| Other tangible fixed assets26 | €6,809 | €6,371 | €5,932 | €5,494 | €5,056 | ▼ 8.0% |
| Financial fixed assets28 | €6,000 | €6,000 | €26,000 | €26,000 | €32,686 | ▲ 25.7% |
| Current assets29/58 | €131,121 | €95,780 | €286,790 | €569,670 | €226,013 | ▼ 60.3% |
| Amounts receivable within one year40/41 | €129,369 | €80,849 | €92,854 | €120,110 | €72,965 | ▼ 39.3% |
| Trade receivables40 | €109,085 | €66,291 | €58,311 | €84,197 | €32,072 | ▼ 61.9% |
| Other amounts receivable41 | €20,284 | €14,557 | €34,543 | €35,912 | €40,893 | ▲ 13.9% |
| Cash at bank and in hand54/58 | - | €10,987 | €188,714 | €447,892 | €153,049 | ▼ 65.8% |
| Deferred charges and accrued income490/1 | €1,752 | €3,944 | €5,222 | €1,669 | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €189,455 | €142,457 | €344,323 | €618,760 | €292,437 | ▼ 52.7% |
| Equity10/15 | -€230,424 | -€296,499 | -€193,857 | €396,454 | €205,342 | ▼ 48.2% |
| Contributions10/11 | €18,600 | €268,600 | €768,600 | €1.8m | €1.8m | = |
| Reserves13 | €4,679 | €4,679 | €4,679 | €4,679 | €4,679 | = |
| Distributable reserves133 | €4,679 | €4,679 | €4,679 | €4,679 | €4,679 | = |
| Profit (loss) carried forward14 | -€253,703 | -€569,779 | -€967,136 | -€1.4m | -€1.6m | ▼ 13.9% |
| Amounts payable17/49 | €419,879 | €438,956 | €538,180 | €222,305 | €87,094 | ▼ 60.8% |
| Amounts payable after more than one year17 | €116,778 | €93,552 | €296,234 | €28,512 | €13,889 | ▼ 51.3% |
| Financial debts170/4 | €116,778 | €93,552 | €296,234 | €28,512 | €13,889 | ▼ 51.3% |
| Amounts payable within one year42/48 | €303,101 | €292,701 | €241,116 | €193,793 | €73,205 | ▼ 62.2% |
| Current portion of amounts payable after more than one year42 | €23,884 | €19,841 | €35,618 | €19,675 | €8,333 | ▼ 57.6% |
| Financial debts43 | €75,830 | €122,000 | €122,000 | €75,000 | - | - |
| Credit institutions430/8 | €75,830 | €122,000 | €122,000 | €75,000 | - | - |
| Trade debts44 | €46,589 | €33,342 | €56,551 | €75,321 | €35,296 | ▼ 53.1% |
| Suppliers440/4 | €46,589 | €33,342 | €56,551 | €75,321 | €35,296 | ▼ 53.1% |
| Taxes, remuneration and social security45 | €13,231 | €29,080 | €25,969 | €23,798 | €29,576 | ▲ 24.3% |
| Taxes450/3 | €414 | €449 | €1,995 | - | €99 | - |
| Remuneration and social security454/9 | €12,817 | €28,631 | €23,974 | €23,798 | €29,477 | ▲ 23.9% |
| Other amounts payable47/48 | €143,568 | €88,439 | €978 | - | - | - |
| Accrued charges and deferred income492/3 | - | €52,703 | €830 | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€215,147 | -€316,075 | -€397,358 | -€409,708 | -€191,112 | ▲ 53.4% |
| + Depreciation and write-downs630 | €15,013 | €13,969 | €13,714 | €12,808 | €19,104 | ▲ 49.2% |
| Operating cash flow (approximation) | -€200,135 | -€302,107 | -€383,643 | -€396,900 | -€172,008 | ▲ 56.7% |
| Investment in fixed assets (approximation) | - | -€2,312 | -€24,570 | -€4,365 | -€36,437 | ▼ 735% |
| Change in cash | - | - | €177,727 | €259,178 | -€294,843 | ▼ 214% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
17-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
31-12
Financial
Weakest financial yearnet -€409,708
Net result drops to -€409,708, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 2.94
Current ratio from 1.19 to 2.94; short-term debt falls from €241,116 to €193,793.
31-12
Financial
Equity above €200,000Eq €396,454
Equity rises from -€193,857 to €396,454.
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
31-12
Financial
Liquidity quadruplescurrent ratio 1.19
Current ratio from 0.33 to 1.19; short-term debt falls from €292,701 to €241,116.
31-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
24-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
28-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
29-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
22-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 22 days late
2018
27-09
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 58 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 10 acts read
About the unread acts
We know of 10 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 10 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 2008
Ground area
2.2 ha
Building footprint
143 m²
Volume, LiDAR
1,060 m³
2 parcels, Flanders · tallest building 12.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
HEALTH MANAGERS
since 20082.175.005.462
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23094D0098/00M000 | Flanders | 2.1 ha | - | - |
| 73090D0694/00L000 | Flanders | 1,379 m² | 1 · 143 m² | 12.5 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Subsidies and aid
Flemish government
2024 to 2025 · 4 entries · 6,098 EUR awarded · 6,098 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 3 | 4,024 EUR | 4,024 EUR |
| 2024 | 1 | 2,074 EUR | 2,074 EUR |
Similar companies · same sector, comparable size
Dr. Vanderlinden Wim
BE 0778.902.971
Leuven · Eq €205,421
FRELACO
BE 0894.389.191
Kortrijk · Eq €205,026
DE ZORGVRIEND
BE 0500.641.942
Brecht · Eq €206,021
TIMMERMANS PHILIPPE
BE 0890.538.093
Brussel · Eq €204,647
MISTAVACK
BE 0839.312.492
Ieper · Eq €206,075
Of 10,428 companies in this sector we hold annual accounts for 885. 648 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded01-08-2008
Fiscal year end31-12
Activities, NACEBEL 2025
71121Engineering and related technical consultancy, excluding land surveyors
86995Nutrition and dietetics services
46460Wholesale of pharmaceutical and medical goods
70200Business and other management consultancy
74999Other professional, scientific and technical activities
Contact
Phone
012/260100
E-invoicing
Reachable via Peppol
Peppol ID
0208:0899601259
Also
9925:BE0899601259
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.